Video

VIDEO: What was the most interesting thing you learned at the meeting?


 

AT SABCS 2014

References

SAN ANTONIO – Our reporter Michele Sullivan asked selected attendees at the San Antonio Breast Cancer Symposium to identify the most interesting or practice-changing study presented at the meeting. The answer was the same across the board - the Suppression of Ovarian Function Trial (SOFT), which showed that selective ovarian suppression reduces disease recurrence in women with early breast cancer.

In our video interview clinicians respond to the implications of the data in their practice.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

FDA approves bevacizumab for ovarian cancer, with chemotherapy
MDedge ObGyn
Mastectomies, reconstruction, on the rise for women with early stage disease
MDedge ObGyn
Bariatric surgery an opportunity to screen for endometrial cancer
MDedge ObGyn
Breast cancer relapse risk halved since 1986
MDedge ObGyn
Ultrasound screening for dense breasts is high cost, offers little benefit
MDedge ObGyn
Pembrolizumab shows efficacy in advanced triple-negative breast cancer patients
MDedge ObGyn
VIDEO: High TILs associated with less efficacy from trastuzumab
MDedge ObGyn
North America has highest rate of obesity-related cancers
MDedge ObGyn
Adjuvant capecitabine adds no advantage to bisphosphonate in elderly breast cancer patients
MDedge ObGyn
SOFT trial endorses selective ovarian suppression in early breast cancer
MDedge ObGyn

Related Articles